New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 13, 2012
14:03 EDTBGMDBG Medicine price target lowered to $7 from $16.50 at Ladenburg
Ladenburg reduced its target on BG Medicine after the company announced that it would transition to a marketing-oriented business model and hire a sales team to sell CardioSCORE. The firm thinks the move will provide the company with greater control over CardioSCOPE, but that the move creates more balance sheet risk and may necessitate the introduction of additional partners. The firm reiterates a Buy rating.
News For BGMD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 13, 2014
10:57 EDTBGMDBG Medicine downgraded to Neutral from Buy at Ladenburg
Ladenburg downgraded BG Medicine to Neutral citing valuation following the company's Q3 results.
06:33 EDTBGMDBG Medicine sees 2014 revenue $2.8M-$3.0M, one estimate $3.10M
Subscribe for More Information
06:32 EDTBGMDBG Medicine reports Q3 EPS (7c), one estimate (7c)
Reports Q3 revenue $695K, one estimate $800.00K.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use